Oxford spin-out MiroBio bought by biopharma leader for £0.3 billion
US biopharmaceutical giant Gilead Sciences has sealed an agreement to purchase the Oxford University spin-out MiroBio in a deal worth an estimated &poun...
Stay updated with breaking news from Nuffield Professor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
US biopharmaceutical giant Gilead Sciences has sealed an agreement to purchase the Oxford University spin-out MiroBio in a deal worth an estimated &poun...
/PRNewswire/ -- Oxford Science Enterprises (OSE), the independent investment company created to found, fund and build transformational businesses via its...
Experts are calling for a five-pronged approach to tackle hesitancy focusing on confidence, complacency, convenience, communication and context.
The reluctance or refusal to accept COVID-19 vaccinations can be tackled by a five-pronged strategy to addressing the behavioral and socio-demographic factors behind vaccine hesitancy. Writing in the Journal of the Royal Society of Medicine, a group of population health, demographic, epidemiology and behavioral scientists propose an approach focused on confidence, complacency, convenience, communication and context.
Staff and patients took to the water to splash out and help kidney patients in Oxford.